Cargando…
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
BACKGROUND: The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociode...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737389/ https://www.ncbi.nlm.nih.gov/pubmed/33317568 http://dx.doi.org/10.1186/s13011-020-00334-x |
_version_ | 1783622932265697280 |
---|---|
author | Vold, Jørn Henrik Gjestad, Rolf Aas, Christer F. Chalabianloo, Fatemeh Skurtveit, Svetlana Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore |
author_facet | Vold, Jørn Henrik Gjestad, Rolf Aas, Christer F. Chalabianloo, Fatemeh Skurtveit, Svetlana Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore |
author_sort | Vold, Jørn Henrik |
collection | PubMed |
description | BACKGROUND: The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociodemographic factors – such as injecting substance use, chronic infectious diseases, liver fibrosis, opioid agonist therapy (OAT), debt difficulties, and housing situation – have on fatigue. METHODS: We used data from a cohort of patients with SUD in Norway with annual health assessments surveying FSS-9 and some clinical and sociodemographic factors. A total of 915 FSS-9 measurements were collected from 654 patients during the period 2016–2020. We defined baseline as the first annual health assessment when the health assessments were listed chronologically. Time was defined as years from baseline. We used a linear mixed model to analyse whether the clinical and sociodemographic factors affected the FSS-9 sum score, presented with beta coefficients (β) with 95% confidence intervals (CI). RESULTS: The mean sum score of the FSS-9 was 43 (standard deviation: 16) at baseline. Females compared with males (adjusted mean difference of FSS-9 sum score: 4.1, 95% CI: 1.3–7.0), having debt difficulties compared with having no debt difficulties (2.9;0.4–5.3), and frequent use of benzodiazepines (5.7;3.0–8.4) or amphetamines (-5.0;-8.0– -2.0) compared to less frequent or no use of these substances changed the FSS-9 baseline sum score. The other clinical and sociodemographic factors did not predict any clinically relevant change in the FSS-9 sum score from baseline to the following health assessments. CONCLUSION: Patients with SUD suffer from high levels of fatigue. Female patients, patients with debt difficulties, and those with extensive use of benzodiazepines are at particular risk of being fatigued. This should be taken into consideration when planning health services. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-020-00334-x. |
format | Online Article Text |
id | pubmed-7737389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77373892020-12-17 Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 Vold, Jørn Henrik Gjestad, Rolf Aas, Christer F. Chalabianloo, Fatemeh Skurtveit, Svetlana Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore Subst Abuse Treat Prev Policy Research BACKGROUND: The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociodemographic factors – such as injecting substance use, chronic infectious diseases, liver fibrosis, opioid agonist therapy (OAT), debt difficulties, and housing situation – have on fatigue. METHODS: We used data from a cohort of patients with SUD in Norway with annual health assessments surveying FSS-9 and some clinical and sociodemographic factors. A total of 915 FSS-9 measurements were collected from 654 patients during the period 2016–2020. We defined baseline as the first annual health assessment when the health assessments were listed chronologically. Time was defined as years from baseline. We used a linear mixed model to analyse whether the clinical and sociodemographic factors affected the FSS-9 sum score, presented with beta coefficients (β) with 95% confidence intervals (CI). RESULTS: The mean sum score of the FSS-9 was 43 (standard deviation: 16) at baseline. Females compared with males (adjusted mean difference of FSS-9 sum score: 4.1, 95% CI: 1.3–7.0), having debt difficulties compared with having no debt difficulties (2.9;0.4–5.3), and frequent use of benzodiazepines (5.7;3.0–8.4) or amphetamines (-5.0;-8.0– -2.0) compared to less frequent or no use of these substances changed the FSS-9 baseline sum score. The other clinical and sociodemographic factors did not predict any clinically relevant change in the FSS-9 sum score from baseline to the following health assessments. CONCLUSION: Patients with SUD suffer from high levels of fatigue. Female patients, patients with debt difficulties, and those with extensive use of benzodiazepines are at particular risk of being fatigued. This should be taken into consideration when planning health services. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-020-00334-x. BioMed Central 2020-12-14 /pmc/articles/PMC7737389/ /pubmed/33317568 http://dx.doi.org/10.1186/s13011-020-00334-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Vold, Jørn Henrik Gjestad, Rolf Aas, Christer F. Chalabianloo, Fatemeh Skurtveit, Svetlana Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 |
title | Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 |
title_full | Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 |
title_fullStr | Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 |
title_full_unstemmed | Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 |
title_short | Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 |
title_sort | impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from norway for the period 2016–2020 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737389/ https://www.ncbi.nlm.nih.gov/pubmed/33317568 http://dx.doi.org/10.1186/s13011-020-00334-x |
work_keys_str_mv | AT voldjørnhenrik impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT gjestadrolf impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT aaschristerf impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT chalabianloofatemeh impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT skurtveitsvetlana impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT løbergelsemarie impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT johanssonkjellarne impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT fadneslarsthore impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 AT impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020 |